专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

CA2261539C METHOD OF PULTRUDING A PART FROM FIBER REINFORCED RESIN WITHA WOOD GRAIN FINISH 未知
公开(公告)号：CA2261539C
公开(公告)日：2002-02-05
申请号：CA2261539
申请日：1999-02-15
申请人： DAVIES LAWRENCE W
发明人： DAVIES LAWRENCE W
IPC分类号： B29C70/52 , B44F9/02
摘要： 11 A wood grain finish to a pultruded part is obtained by applying to a surface of the part before entering the die a strip carrying male projection s shaped in differential depths and spacing across the width of the part to form a simulated wood grain pattern. The strip is then removed after the part is set leaving recesses in the outside surface which provide a simulated wood grain finish which can be differentially stained.

2. 发明专利

CA2261539A1 METHOD OF PULTRUDING A PART FROM FIBER REINFORCED RESIN WITH A WOOD GRAIN FINISH 未知
公开(公告)号：CA2261539A1
公开(公告)日：1999-09-03
申请号：CA2261539
申请日：1999-02-15
申请人： DAVIES LAWRENCE W
发明人： DAVIES LAWRENCE W
IPC分类号： B29C70/52 , B44F9/02
摘要： A wood grain finish to a pultruded part is obtained by applying to a surface of the part before entering the die a strip carrying male projections shaped in differential depths and spacing across the width of the part to form a simulated wood i grain pattern. The strip is then removed after the part is set leaving recesses in the outside surface which provide a simulated wood grain finish which can be differentially stained.

3. 发明专利

GB0822879D0 A support 未知
公开(公告)号：GB0822879D0
公开(公告)日：2009-01-21
申请号：GB0822879
申请日：2008-12-16
申请人： DAVIES LAWRENCE W

4. 发明申请

WO1996012611A1 PULTRUDED PART WITH COVERING VENEER 审中-公开
标题翻译：带有覆盖翼的搅拌部件
公开(公告)号：WO1996012611A1
公开(公告)日：1996-05-02
申请号：PCT/CA1995000599
申请日：1995-10-24
申请人： OMNIGLASS LTD. , DAVIES, Lawrence, W.
发明人： OMNIGLASS LTD.
IPC分类号： B29C70/54
CPC分类号： B29C70/525
摘要： A conventional pultruded window frame is modified by the addition of a wood veneer (40) applied onto only those surfaces of the pultruded window frame which will constitute inside surfaces after completion of the window frame structure. The wood veneer is applied during the pultrusion process by drawing the wood veneer through the die (36) (so as to be applied directly onto the outside surface of the resin as the resin sets). An inside surface (52) of the veneer is directly applied onto the resin for aggressive bonding of the resin to the wood veneer. An outside surface (53) of the wood veneer is covered by a paper layer (41) which prevents the attractive outer surface of the wood veneer from becoming covered with the resin. A soaking (42) of the wood veneer is effected prior to forming for passage through the die to prevent penetration of the resin through the veneer to the outer surface which would effect contamination of the surface.
摘要翻译：常规的拉挤玻璃框架通过添加仅在窗框架结构完成之后构成内表面的拉挤玻璃框架的那些表面上的木材单板（40）被修改。在拉挤成型过程中，通过将木材单板通过模具（36）（以树脂的形式直接施加在树脂的外表面上）来施加木材单板。单板的内表面（52）被直接施加到树脂上，用于将树脂与木单板进行积极的粘接。木材单板的外表面（53）被纸层（41）覆盖，纸层（41）防止木材单板的有吸引力的外表面被树脂覆盖。木材单板的浸泡（42）在成形之前在通过模具之前进行，以防止树脂穿过薄板穿过外部表面，这将影响表面的污染。

5. 发明申请

WO1992003277A1 PULTRUSION METHOD INCLUDING TRANSVERSE FIBERS 审中-公开
标题翻译：包括横向纤维的挤压方法
公开(公告)号：WO1992003277A1
公开(公告)日：1992-03-05
申请号：PCT/CA1991000285
申请日：1991-08-16
申请人： OMNIGLASS LTD. , DAVIES, Lawrence, W.
发明人： OMNIGLASS LTD.
IPC分类号： B29C67/14
CPC分类号： B29C70/081 , B29C47/0004 , B29C47/003 , B29C47/02 , B29C47/1045 , B29C47/28 , B29C70/521 , B29K2105/06 , B29K2105/12
摘要： Transverse fibers are added to a pultruded part by forming a body of the fibers and resin in a first die part which body is dimensioned smaller than that of the die through which the body is to be passed. A fluid including cut fibers is then applied under pressure to the body just upstream of the die so that the cut fibers become integrated with the body into the spaces defined in the body. The continuous fibers, the cut fibers and the resin are then passed through the die and become integrateed into a pultruded part with the transverse cut fibers providing a transverse strength.
摘要翻译：通过在第一模具部分中形成纤维和树脂体，将横向纤维加入到拉挤部分中，该第一模具部分的尺寸小于待通过的模具的尺寸。然后将包括切割的纤维的流体在压力下施加到刚好在模具上游的身体，使得切割的纤维与身体整合到体内限定的空间中。然后将连续纤维，切割的纤维和树脂通过模头并整合成拉挤部分，横切纤维提供横向强度。

6. 发明申请

WO2007125330A1 IMIDAZO[4, 5-B]PYRIDIN-2-ONE AND OXAZOLO[4, 5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS 审中-公开
标题翻译：咪唑并[4,5-B]吡啶-2-酮和氧杂唑[4,5-B]吡啶-2-酮化合物及其作为癌症治疗化合物的模拟物
公开(公告)号：WO2007125330A1
公开(公告)日：2007-11-08
申请号：PCT/GB2007/001534
申请日：2007-04-26
申请人： CANCER RESEARCH TECHNOLOGY LIMITED , INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) , ASTEX THERAPEUTICS LIMITED , NICULESCU-DUVAZ, Dan , SPRINGER, Caroline, Joy , MARAIS, Richard, Malcolm , DIJKSTRA, Harmen , MENARD, Delphine , NICULESCU-DUVAZ, Ion , DAVIES, Lawrence , NOURRY, Arnaud
发明人： NICULESCU-DUVAZ, Dan , SPRINGER, Caroline, Joy , MARAIS, Richard, Malcolm , DIJKSTRA, Harmen , MENARD, Delphine , NICULESCU-DUVAZ, Ion , DAVIES, Lawrence , NOURRY, Arnaud
IPC分类号： C07D471/04 , A61K31/437 , A61K31/5377 , A61K31/44 , A61P35/00
CPC分类号： C07D471/04
摘要： The present invention pertains to certain imidazo[4,5-b]pyridin-2-one and oxazolo[4,5 b]pyridin-2-one compounds and analogs thereof, which, inter alia , inhibit RAF (e.g., B RAF) activity, inhibit cell proliferation, treat cancer, etc., and more particularly to compounds of the formulae: wherein: J is independently -O- or -NR N1 - ; R N1 , if present, is independently -H or a substituent; R N2 is independently -H or a substituent; Y is independently -CH= or -N=; Q is independently -(CH 2 ) j -M-(CH 2 ) k - wherein: j is independently 0, 1 or 2; k is independently 0, 1, or 2; j+k is 0, 1, or 2; M is independently O-, -S-, -NH-, -NMe-, or -CH 2 -; each of R P1 , R P2 , R P5 , and R P4 is independently -H or a substituent; and additionally R P1 and R P2 taken together may be CH=CH-CH=CH-; and additionally R P1 and R P5 taken together may be CH=CH-CH=CH-; L is independently: a linker group formed by a chain of 2, 3, or 4 linker moieties; each linker moiety is independently CH 2 -, -NR N -, -C(=X)-, or -S(=O) 2 -; either: exactly one linker moiety is -NR N -, or: exactly two linker moieties are -NR N -; either: exactly one linker moiety is -C(=X)-, and no linker moiety is -S(=O) 2 -, or: exactly one linker moiety is -S(=O) 2 -, and no linker moiety is -C(=X)-; no two adjacent linker moieties are -NR N -; X is independently =O or =S; each R N is independently -H or a substituent; A is independently: C 6-14 carboaryl, C 5-14 heteroaryl, C 3-12 carbocyclic, C 3-12 heterocyclic; and is independently unsubstituted or substituted; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, N-oxides, chemically protected forms, and prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit RAF (e.g., B-RAF) activity, to inhibit receptor tyrosine kinase (RTK) activity, to inhibit cell proliferation, and in the treatment of diseases and conditions that are ameliorated by the inhibition of RAF, RTK, etc., proliferative conditions such as cancer (e.g., colorectal cancer, melanoma), etc.
摘要翻译：本发明涉及特定的抑制RAF（例如B RAF）的咪唑并[4,5-b]吡啶-2-酮和恶唑并[4,5-b]吡啶-2-酮化合物及其类似物，活性，抑制细胞增殖，治疗癌症等，更具体地涉及下式的化合物：其中：J独立地为-O-或-NR N1。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式